… . Rituximab usage in systemic lupus erythematosus-associated antiphospholipid
syndrome: a single-center experience. Semin Arthritis Rheum 2016;46:102–8.doi:10.1016/j.semarthrit.…

Antiphospholipid Syndrome (APS) is a form of immune mediated thrombophilia, presenting …
, in association with positive laboratory tests for antiphospholipid antibodies (APA) in the form …

… Approximately 30–40 % of APL-positive individuals with autoimmune disorders
experience … GAPSS: role of thrombotic risk assessment in the real-life setting. Lupus. 2017;26:1328–32. …

… of APS, especially concerning patients who experience recurrent thrombosis while on standard
… option for three APS patients who experienced recurrent arterial or venous thrombosis, …

… published experience of 130 cases with this syndrome. We … real prevalence and the best
therapy for this life-threatening condition. The term “catastrophic” antiphospholipid syndrome (…

… However, when patients present with multiple organ thromboses in a “real-world” setting,
especially … Dosage was taken from previous experience on other thrombotic microangiopathies. …

… response, both patients experienced clinical improvement and … on our experience, patients
generally continue to experience dis… No diagnostic criteria exist for CAPS, and in a real- world …

… the “real-world” situation, as many doctors are still reluctant to prescribe any drug for primary
thromboprophylaxis to those female patients with APS who had experienced pregnancy …

… ) are increasingly used in antiphospholipid syndrome (APS). … K antagonists (VKAs) in real-life
consecutive APS patients. … %) experienced stroke/TIA and 16 (19%) subjects experienced …

… project started in 1999 as an attempt to describe the course of APS patients in the real life
in … the UK) participated in the study with experienced physicians in the management of APS …